0.4850EUR-3.77%Mkt Cap: 34.79M EURP/E: —Last update: 2026-05-14
Theraclion SA provides therapeutic ultrasound equipment. It offers SONOVEIN, a robotic solution for the non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for the echothe…
Industry Peers
Medical Devicesloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)4.76
PEG—
P/B-11.07
P/S53.37
EV/EBITDA-4.94
EV/Revenue55.70
EPS (TTM)-0.09
EPS (Forward)0.10
Cash Flow & Leverage
FCF Yield-18.06%
FCF Margin-963.57%
Operating CF-2.91M EUR
CapEx (TTM)102.00K EUR
Net Debt/EBITDA-1.07
Net Debt7.85M EUR
Technical
SMA 500.4976 (-2.5%)
SMA 2000.6239 (-22.3%)
Beta0.26
S&P 52W Chg24.23%
Avg Vol (30d)143.71K
Avg Vol (10d)270.62K
Technical Indicators
RSI (14)46.0
MACD0.0039
MACD Signal0.0061
MACD Hist.-0.0022
BB Upper0.6015 EUR
BB Middle0.5120 EUR
BB Lower0.4225 EUR
BB Width34.96%
ATR (14)0.0586 EUR
Vol Ratio (20d)1.94x
52W Range
0.276021% of range1.250
52W High1.250 EUR
52W Low0.2760 EUR
Profitability
Gross Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
Oper. Margin1688.36%
ROE—
ROA-40.38%
Revenue Growth—
Earnings Growth—
Balance Sheet
Debt/Equity-11369.81
Current Ratio2.79
Quick Ratio1.85
Book Value/Sh-0.0430 EUR
Cash/Share0.0570 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Ownership
Shares Out.73.10M
Float26.69M
Insiders55.50%
Institutions0.00%
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Company
Market Cap34.79M EUR
Enterprise Value36.32M EUR
Revenue (TTM)652.00K EUR
Gross Profit-3.07M EUR
Net Income (TTM)-5.69M EUR
Revenue/Share0.0110 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees36
Last Price0.4850 EUR
CountryFR
SectorHealthcare
IndustryMedical Devices
ISINFR0010120402